This commentary on a case considers a transgender patient’s mental health and risk for DVT in ethical decision making about feminizing gender-affirming hormone therapy.
AMA J Ethics. 2023;25(6):E386-390. doi:
10.1001/amajethics.2023.386.
Annika Brakebill, A. Mark Fendrick, MD, and Jeffrey T. Kullgren, MD, MS, MPH
These key steps are ones health sector stakeholders should take to help patients and clinicians use pricing information to inform health decision making.
AMA J Ethics. 2022;24(11):E1034-1039. doi:
10.1001/amajethics.2022.1034.
Watie White joins Ethics Talk to discuss his article, coauthored with Dr Regina Idoate, Aislinn C. Rookwood, Sophia A. Quintero, Shelby Larson, Dr Arturo Aceves, and Dr Keyonna M. King: “Lead Toxicity and Environmental Health Justice Stories in Black and White Woodcut Portraits.”
Regina Idoate, PhD, Aislinn C. Rookwood, MPH, Sophia A. Quintero, MPH, Watie White, MFA, Shelby Larson, MPH, Arturo Aceves, MD, and Keyonna M. King, DrPH, MA
Healthy Housing Omaha, an environmental health nonprofit, partnered with an artist and a newspaper to raise awareness of lead poisoning.
AMA J Ethics. 2022;24(7):E599-610. doi:
10.1001/amajethics.2022.599.
Isabelle M. Mikell joins Ethics Talk to discuss her article, coauthored with Courtney L. Savage Hoggard and Dr Harald Schmidt: "What Should Be Roles of Federal Clinician Governors in Motivating Equity in Locally Coordinated Triage Protocols?"
AMA Journal of Ethics theme editor Natasha Dolgin, an MD/PhD candidate at the University of Massachusetts School of Medicine, interviewed Dorry Segev, MD, PhD, about organ allocation policy and geographic disparities in access, possible ways to maximize equity, and advice physicians should give their patients between policy changes.
When the patient delivers a low-birth-weight infant that requires extensive time in the neonatal intensive, should she be held responsible? Where do we draw the line? More importantly, on what basis do we draw the line?